Cargando…
Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO
Hepatocellular carcinoma (HCC) is one of the most common primary cancers with limited therapeutic options. Melatonin, a neuroendocrine hormone produced primarily by the pineal gland, demonstrates an anti-cancer effect on a myriad of cancers including HCC. However, whether melatonin could suppress tu...
Autores principales: | Bai, Lu, Sun, Siwen, Su, Wenmei, Chen, Chaoqun, Lv, Yuesheng, Zhang, Jinrui, Zhao, Jinyao, Li, Man, Qi, Yangfan, Zhang, Wenjing, Wang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548564/ https://www.ncbi.nlm.nih.gov/pubmed/36225557 http://dx.doi.org/10.3389/fphar.2022.1007006 |
Ejemplares similares
-
SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer
por: Lv, Yuesheng, et al.
Publicado: (2021) -
Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype
por: Lee, Younglang, et al.
Publicado: (2022) -
Modulation of alternative splicing induced by paclitaxel in human lung cancer
por: Zhu, Ziran, et al.
Publicado: (2018) -
SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance
por: Sheng, Junxiu, et al.
Publicado: (2018) -
Aberrant alternative splicing in breast cancer
por: Yang, Quan, et al.
Publicado: (2019)